Biosimilar Comparability Webinar

February 10, 2015 10:49 AM

BioOutsource Ltd., a biologics contract testing and biosimilar characterization company for the biopharmaceutical industry, announced that it will be hosting a free webinar on Thursday, 12 February 2015, at 3:00 p.m. GMT / 10:00 a.m. EST.

With a specific emphasis on the critical importance of going through a comprehensive and orthogonal characterization process using assays capable of detecting subtle differences between molecules, the webinar will be hosted by BioOutsource scientists Sarah Stone, PhD, and Andrew Baron, PhD. Dr. Stone is an expert in the characterization of biosimilar monoclonal antibody-based therapies for some of the most well-known molecules such as Rituximab and Etanercept. With a PhD in neuroscience, Dr. Baron developed some of BioOutsource’s most popular off-the-shelf assay packages to support biosimilar development, and leads a dedicated team performing bioassays and and binding assays in BioOutsource’s Biosimilar Centre of Excellence.

More information and complimentary registration is available on BioOutsource home page.

Would you like to post an event on Biosimilar News?

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!